Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAART-treated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00326716
What this trial is testing

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
Bristol-Myers Squibb 69
Not applicableStudy completedNCT02526940
What this trial is testing

Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men

Who this might be right for
Human Immunodeficiency Virus
Centre Hospitalier Universitaire de Saint Etienne 30
Large-scale testing (Phase 3)Study completedNCT02005900
What this trial is testing

Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.

Who this might be right for
HIV-associated HypertriglyceridemiaHIV-associated HypercholesterolemiaHIV-associated Inflammatory State
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 66
Not applicableStudy completedNCT00247845
What this trial is testing

Evaluation of Atazanavir Substitution Intervention (EASI) Study

Who this might be right for
HIV Infections
University of British Columbia 100
Post-approval studies (Phase 4)Study completedNCT00256828
What this trial is testing

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Who this might be right for
HIV Infections
Clinical Trial Agency of HIV Study Group 360
Post-approval studies (Phase 4)Looking for participantsNCT07357584
What this trial is testing

Efficacy and Safety of Doravirine in the Rapid Initiation

Who this might be right for
HIV-1-infection
Fundación Huésped 100
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Testing effectiveness (Phase 2)Ended earlyNCT00076804
What this trial is testing

Helping HIV Infected Patients in South Africa Adhere to Drug Regimens

Who this might be right for
HIV Infections
Johns Hopkins University 274
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Large-scale testing (Phase 3)Study completedNCT00408642
What this trial is testing

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Centre for the AIDS Programme of Research in South Africa 297
Not applicableStudy completedNCT00463086
What this trial is testing

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Who this might be right for
TuberculosisLatent Tuberculosis InfectionHIV Infections
University of Cape Town 1,368
Testing effectiveness (Phase 2)Study completedNCT00031070
What this trial is testing

Increasing HAART-Induced Immune Restoration With Cyclosporine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00518154
What this trial is testing

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Who this might be right for
HIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 7
Testing effectiveness (Phase 2)Study completedNCT00672191
What this trial is testing

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

Who this might be right for
HIV Infections
Argos Therapeutics 59
Post-approval studies (Phase 4)Study completedNCT00875368
What this trial is testing

Maraviroc Immune Recovery Study

Who this might be right for
HIV Infections
S.F.L. van Lelyveld 85
Testing effectiveness (Phase 2)WithdrawnNCT01515813
What this trial is testing

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Not applicableStudy completedNCT01044810
What this trial is testing

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

Who this might be right for
Treatment Failure, HIV or AIDSCD4 Cell Counts
Bamrasnaradura Infectious Diseases Institute 559
Large-scale testing (Phase 3)Study completedNCT00433056
What this trial is testing

Long Term Treatment Interruptions

Who this might be right for
HIV InfectionsAIDS
A.O. Ospedale Papa Giovanni XXIII 320
Large-scale testing (Phase 3)Study completedNCT00528892
What this trial is testing

Switching From PI to RALtegravir in HIV Stable Patients

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 282
Next Page